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Abstract.  Hepatitis B surface antigen  (HBsAg), the 
major coat protein of hepatitis B virus,  is also in- 
dependently secreted from infected cells as a lipopro- 
tein particle.  Secretion proceeds without signal se- 
quence removal or cleavage of other segments of the 
polypeptide. We have examined the synthesis and 
transport of HBsAg in cultured cells expressing the 
cloned surface antigen gene.  Our results show that 
HBsAg is initially synthesized as a  integral membrane 
protein.  This transmembrane  form is slowly converted 
to a  secreted lipoprotein complex in the lumen of the 
endoplasmic reticulum via a series of definable inter- 
mediates, after which it is secreted from the cell.  This 
unusual export process shares many features with the 
assembly and budding reactions of conventional envel- 
oped animal viruses.  However, it differs importantly in 
its absence of a requirement for the participation of 
nucleocapsid or other viral proteins. 
T 
hE  hepatitis  B  virus surface antigen  (HBsAg) m  is a 
24-kD protein  (also  called  p24s) that  is encoded by 
the viral S gene.  p24s and its glycosylated derivative 
(gp27s) are the major proteins in the virion outer coat. In the 
virus particle,  this coat envelopes a nucleocapsid composed 
of a partially double-stranded DNA genome surrounded by 
core proteins.  One of the remarkable features of HBsAg is 
that, unlike most viral envelope glycoproteins, both p24s and 
gp27s are also independently  secreted from infected cells as 
subviral  lipoprotein  particles.  Analysis  of secreted HBsAg 
reveals that,  unlike other secreted proteins,  no amino acids 
are cleaved from the polypeptide during membrane translo- 
cation and export (4, 11, 13, 14, 18, 20). Notably, all the viral 
information  required for particle formation  and export re- 
sides within the S coding  region:  cultured cell lines  which 
are stably transformed  with the S gene alone can assemble 
and secrete HBsAg particles in the absence of other viral 
proteins (4,  11,  13,  14,  16,  17). 
Though  HBsAg has no cleaved signal sequence,  analysis 
of its amino acid sequence reveals an uninterrupted  stretch 
of hydrophobic  residues at positions 80-98. Two other hy- 
drophobic regions are also encoded, one at positions 3-22, 
which contains  no charged  residues,  and the other at posi- 
tions 170-226 in which 77% of the amino acids are hydro- 
phobic. Recently, Eble et al. (5, 6) showed that when HBsAg 
mRNA is translated  in vitro in the presence of microsomal 
vesicles, the HBsAg polypeptide is synthesized as an integral 
transmembrane  protein that spans the bilayer at least twice. 
These results  raise  several important  questions.  Are trans- 
membrane forms of HBsAg also synthesized  in vivo? If so, 
1. Abbreviations  used in this paper:  ER, endoplasmic reticulum; HBsAg, 
hepatitis B virus surface antigen. 
by what mechanism are they able to extricate  themselves 
from cellular  membranes and be secreted? In this study we 
examine the biogenesis of HBsAg particles with particular 
reference to these questions. 
Materials and Methods 
Materials 
Rabbit anti-sAg antisera was obtained from Cappel Laboratories (Cochran- 
ville, PA). Trypsin and proteinase K were from Boehringer Mannheim Di- 
agnostics, Inc.  (Houston, TX).  135S]methionine was from New England 
Nuclear (Boston, MA). 
Cell Lines and Plasmids 
Plasmid pSV24H was constructed by cloning the 1.9-kb  Eco RI-Bg LII 
fragment of HBV (subtype adw) into the Eco RI- and Bam HI-cleaved plas- 
mid pSV65; the latter is a derivative of pSP65 bearing the 343-bp SV-40 
Pvu II-Hind III fragment containing the SV-40 early promoter and ori se- 
quences. In the resulting recombinant, the HBV S gene and its polyadenyla- 
tion signal are under the control of the SV-40 early promoter (cf. reference 
19).  The plasmid was introduced into mouse Ltk- cells together with the 
HSV TK gene by calcium phosphate coprecipitation and tk  ÷ cells selected 
in HAT medium as previously described (18). 
Pulse-Chase Analysis 
Cells were grown in DME-H16 medium containing 10% FCS. For labeling, 
10-cm dishes of cells grown to subconfluence were preincubated for 30 rain 
in 3 ml of medium without methionine and subsequently incubated for 1 h 
in 3 ml of medium containing 100 ~tCi/ml  [3SS]methionine.  After the la- 
beling period, the medium was removed and replaced with medium contain- 
ing 200 mM unlabeled methionine, and cells were then chased for varying 
periods of time. At the end of each chase period, the medium was removed 
and diluted 1:1 into buffer A (0.1 M Tris-HCl, pH 8.0, 0.1 M NaCI, 0.1 M 
EDTA, 2% Triton X-100, 0.1% SDS, 1 mM phenylmethyisulfonyl fluoride 
[PMSF]); the cells were washed twice in PBS and then lysed in 2 ml of 
buffer A. The extract was spun at 10,000 g for 10 s to remove cellular debris. 
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15 ~tl protein A-Sepharose. 
Immunoprecipitation of  sAg Translation Products 
2-10 btl of antisera was added to each sample,  and samples were incubated 
overnight at 4°C.  After the incubation, 15 ~tl of a 50% slurry of protein 
A-Sepharose in buffer A was added.  Samples were incubated for 1 h at 4°C, 
washed three times with buffer A, and twice subsequently  with buffer con- 
taining 0.1 M Tris-HCI (pH 7.5) and 0.1 M NaCI to remove residual Triton 
X-100. 
Crude Vesicle  Preparation 
Freshly labeled ceils were washed twice with ice-cold PBS, and were then 
resuspended in 600 lal of an iso-osmotic buffer solution (buffer B) that con- 
mined 20 mM Tris-HCl  (pH 7.6), 150 mM NaC1, 10 mM MgAc, and 10% 
sucrose (wt/vol). A crude vesicle preparation was obtained by homogeniza- 
tion with a ground-glass homogenizer,  followed by a lO-s spin at i0,000 g 
to remove cellular debris. 
Protease Protection 
10-cm dishes of L cells were preincubated for 40 min in medium without 
methionine and then pulse-labeled in 3 ml medium containing 3 mCi/ml of 
[35Slmethionine. After the incubation period, crude vesicles were prepared 
as described above.  Each sample was divided into three equal aliquots  of 
150 ~tl each, and these samples  were then incubated at 4°C for 3 h either 
in the absence of proteinase K, in the presence of 3 mM proteinase K, or 
in the presence ofproteinase K and 1% Triton X-100. Protease digestion was 
stopped by the addition of 2 mM PMSF followed by boiling in 2 ×  volume 
2% SDS in 0.1 M Tris-HC1 (pH 8.9) for 10 min. For immunoprecipitation, 
all samples were diluted  10-fold in buffer A. 
Carbonate Extraction 
Vesicles were prepared as described.  Each sample was divided into two ali- 
quots of 50 ~tl each, and one aliquot was treated with 5 ml 0.1 M Na2CO3 
(pH 11.0) for 30 min at 4°C. The extracted sample was then centrifuged  for 
45 min at 100,000 g in an ultracentrifuge.  The top 4 ml was removed (super- 
natant), 900 I~1 of the remaining 1 ml of solution was discarded, and the 
remaining 100 lxl and pellet was resuspended in buffer A with 0.1% SDS. 
The supernatant was neutralized  by addition of acetic acid and then added 
to I ml of 5 x concentration  buffer A including 0.5 % SDS. All samples were 
immunoprecipitated  as decribed above. 
Results 
We used a mouse L cell line stably transformed by a plasmid 
in which transcription of the S gene is driven by the SV-40 
early promoter; construction of this plasmid and the trans- 
fection procedures are described in Materials and Methods 
(18,  19).  To determine what percentage of the total HBsAg 
products were secreted by this cell line,  we performed the 
pulse-chase experiment shown in Fig. 1. Cells were pulse la- 
beled for 1 h in incubation medium containing  [35S]methio- 
nine and then chased in medium containing excess unlabeled 
methionine for varying time intervals. At the end of each in- 
cubation period, medium and cells were harvested and ana- 
lyzed by immunoprecipitation with anti-HBsAg antisera, fol- 
lowed by gel electrophoresis. The results of this experiment 
show that >95% of the HBsAg synthesized is secreted within 
a  10 h  time period,  and that the half-time  for secretion is 
'~3 h.  Both p24s and gp27s are released into the medium 
with similar kinetics. In previous studies, we (18) and others 
(4,  11,  13,  14) have shown that the material  secreted from 
such transformed cell lines is particulate,  as judged by elec- 
tron microscopy and by equilibrium density centrifugation in 
CsC1. 
Having established that this cell line secreted HBsAg with 
high efficiency, we then characterized the translocation prop- 
erties  of newly  synthesized  surface  antigen  polypeptides. 
First,  we used proteolytic digestion of vesicle preparations 
to determine  whether the  transmembrane  form previously 
observed  in  cell-free  systems is  also  synthesized  in  vivo. 
Figure 1.  HBsAg is efficiently secreted from murine L  cells.  (A) Cells were pulse labeled for 1 h  in medium containing [35S]methionine 
and then chased for the times indicated (in hours).  At each time point, medium was collected and cell homogenates were prepared by 
detergent extraction. Labeled products were immunoprecipitated with anti-HBsAg antiserum and visualized by gel electrophoresis. HOM 
refers to  the homogenate prepared  from  lysed  cells,  and MED refers  to  the medium.  P24  and  gp27  refer to the unglycosylated and 
glycosylated forms of HBsAg, respectively. (B) Products visualized in A were quantitated by scanning densitometry and were plotted as 
percent of total product secreted vs. time. Total product is calculated as the sum of homogenate and medium at each individual time point. 
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and a crude vesicle extract was prepared by homogenization 
in iso-osmolar buffer. Vesicles were incubated in the pres- 
ence of proteinase K  under conditions that had previously 
been shown to digest the transmembrane form produced in 
vitro (5). The results of this experiment are shown in Fig. 
2 A.  Lane 1  shows the 24-kD (p24S) form of HBsAg seen 
in the absence of proteinase K. In the presence of proteinase 
K  (Fig.  2  A,  lane 2),  all of the detectable HBsAg peptide 
chains have shifted down to a molecular mass of •17,000  D 
(labeled F). This shift down in molecular mass is identical 
to the change previously observed (5) when proteolysis was 
performed on the products generated in cell-free translation/ 
translocation experiments.  A  control experiment in which 
vesicles were incubated with proteinase K in the presence of 
Triton X-100 (Fig. 2 A, lane 3) demonstrates that the poly- 
peptides are extensively degraded under the same conditions 
when the vesicles are not intact.  Because all of the HBsAg 
detected at this early time point is susceptible to protease, we 
conclude that HBsAg in these cells is initially synthesized as 
a transmembrane protein. 
Greater than 95 % of the synthesized HBsAg polypeptides 
are eventually secreted as a lipoprotein complex; therefore, 
a mechanism for the dissociation of these peptides from the 
ER membrane must exist. To further characterize the molec- 
ular events underlying this process, we examined in detail the 
events subsequent to the initial  synthesis of the transmem- 
brane form. To detect changes in the membrane association 
of HBsAg polypeptides that might occur subsequent to initial 
synthesis and translocation, ceils were incubated in the pres- 
ence of [35S]methionine  for longer time periods before pre- 
paring vesicles and subjecting them to protease digestion. 
The results of experiments in which cells were pulse labeled 
for either 20 or 40 min are shown in Fig. 2 A. Quantitation 
of these results by scanning densitometry reveals that after 
a 20-min incubation, 50 % of the chains have been converted 
Figure 2. Digestion of vesicle prepa- 
rations with proteinase K shows that 
HBsAg is converted from a protease- 
sensitive to a prom-resistant form. 
(A) Ceils  were  pulse  labeled  for 8 
(lanes  1-3),  20  (lanes  4-6),  or 40 
(lanes  7-9)  min  with  [35S]methio- 
nine.  At  each time point,  vesicles 
were prepared  and incubated either 
in the absence of proteinase K (lanes 
1, 4, and 7), in the presence of pro- 
teinase K (lanes 2, 5, and 8), or in 
the presence of proteinase K and 1% 
Triton X-100 (lanes 3, 6, and 9). F 
denotes the fragment generated from 
protease digestion of the exposed re- 
gion of HBsAg. Products were visu- 
alized by immunoprecipitation  with 
anti-HBsAg  antisera  followed  by 
SDS-PAGE.  (B)  Cells  were  either 
pulse labeled for 20 min (lanes 1-3) 
in  medium  containing  [35S]methio- 
nine or pulse labeled for 20 min fol- 
lowed by a 1-h chase (lanes 4-6) in 
medium  containing  excess  methio- 
nine.  After  the  incubation  period, 
cells  were  harvested  and  vesicles 
were prepared and subsequently  in- 
cubated with proteinase K in the ab- 
sence  (lanes 2  and  5)  or presence 
(lanes 3 and 6) of  Triton X-100. Lanes 
I and 4 are control samples that were 
incubated in the absence of protein- 
ase K. Products were visualized  by im- 
munoprecipitation with anti-HBsAg 
antisera followed by SDS-PAGE. (C) 
Cells were either pulse labeled for 20 
min with  [35S]methionine and  then 
harvested (0 h of  chase) or chased for 
1 h in medium containing excess un- 
labeled  methionine  (1  h  of chase). 
Samples  were  immunoprecipitated 
with anti-HBsAg antiserum and ana- 
lyzed by SDS-PAGE. 
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after a 40-min pulse, >80 % of the antigen has become pro- 
tease resistant (Fig. 2 A, lanes 7-9). A small amount of the 
protease-sensitive transmembrane form (labeled F) is seen 
after a  40-min labeling period (Fig.  2  A,  lane 8);  this  is 
generated from cleavage of chains synthesized at the end of 
the labeling period before sufficient time has elapsed for con- 
version to the protease-resistant form. These studies suggest 
that  conversion  of  p24s  from  a  protease-sensitive  to  a 
protease-resistant form is almost complete in <1  h. 
To demonstrate more clearly that the changes we observed 
were in fact due to a conversion of the transmembrane form 
to a  protease-resistant form,  we  also performed a  pulse- 
chase analysis in which cells were pulse labeled for 20 min 
(Fig. 2 B, lanes 1-3), and then chased for 1 h (Fig. 2 B, lanes 
4-6) before preparing vesicles and digesting with protease. 
As before, about half of the antigen is in a transmembrane 
form (labeled F) after a 20-min pulse; after a 1-h chase, vir- 
tually all of the transmembrane HBsAg form has disappeared 
and has been converted to a protease-resistant form. A con- 
trol experiment in which cells were labeled for 20 min (Fig. 
2 C, lane 1 ) and then chased for 1 h (Fig. 2 C, lane 2) demon- 
strates that there has been no incorporation of isotope or 
degradation of the protein during the chase period. We con- 
clude that by 1 h subsequent to the initial synthesis of HBsAg, 
there has been a quantitative conversion of the HBsAg poly- 
peptide  chains  from  a  protease-sensitive  to  a  protease- 
resistant form. 
What is the nature of the protease-resistant material? One 
interpretation is that these HBsAg chains have been trans- 
ferred into the endoplasmic reticulum (ER) lumen. Alterna- 
tively, protease resistance could be due to a change in poly- 
peptide conformation and/or to aggregation into complexes 
which, though still in the ER membrane, are no longer ac- 
cessible to protease. 
To determine whether the acquisition of protease resis- 
tance represents an actual transfer of polypeptide chains into 
the ER lumen,  we next performed a  pulse-chase analysis 
coupled with extraction of vesicles in  Na2CO3 (pH  11.0). 
This  procedure distinguishes  between  integral  membrane 
proteins (which are embedded in the lipid bilayer and cannot 
be extracted in the absence of nonionic detergents) and pro- 
teins that are either soluble or associated with the membrane 
by electrostatic interactions that are disrupted by the low salt 
concentration and high pH of the carbonate buffer. After in- 
cubation with alkali, the treated vesicles are centrifuged to 
separate extracted proteins (supernatant) from proteins re- 
maining associated with vesicle membranes (pellet); prod- 
ucts from each fraction were immunoprecipitated and visual- 
ized by SDS-PAGE. In previous studies, we have established 
that secreted HBsAg particles,  like more conventional se- 
creted proteins, remain in the supernatant after pH 11 extrac- 
tion and sedimentation (22). 
The HBsAg chains visualized after a  15-min pulse were 
not extracted with alkali;  all remained associated with the 
vesicle pellet (Fig.  3,  lanes 1 and 2).  To our surprise,  we 
found that even when cells were pulse labeled for 15 min and 
subsequently chased for as long as 1 h (Fig. 3, lanes 3 and 
4), none of the detectable HBsAg had become carbonate ex- 
tractable, even though by this time >80% of the polypeptide 
chains are protease resistant.  Similarly, after a  2-h chase 
(Fig.  3,  lanes 5  and 6),  only 31%  of the HBsAg was car- 
bonate extractable, as judged by densitometric analysis of the 
data. However, after a 4-h chase (Fig. 3, lanes 7and 8), 70% 
of the HBsAg proteins were extractable with carbonate, indi- 
cating  that  intracellular  assembly  of the  particulate  form 
does eventually result in the appearance of HBsAg polypep- 
tides that no longer display the behavior of  typical transmem- 
brane proteins. 
Discussion 
The above results outline a number of biochemically assay- 
able steps in the biogenesis of secreted surface antigen parti- 
cles and suggest a model for the mechanism of particle for- 
mation  (cf.  Fig.  4).  HBsAg  is  initially  synthesized as  a 
transmembrane protein, even in cells that efficiently secrete 
this protein. Within 1 h, this material is converted to a form 
that in our assays is protease resistant, but not extractable 
with carbonate. We suggest that this second form represents 
polypeptide chains  that  have undergone a  conformational 
change and/or aggregation in the lipid bilayer in such a way 
as to make them no longer susceptible to protease; this par- 
tially assembled form must be composed of proteins that are 
still embedded in the lipid bilayer, since they are resistant to 
carbonate extraction. In the third step, the assembled HBsAg 
Figure 3. Newly synthesized HBsAg becomes carbonate 
extractable within a period of hours. Cells were pulse la- 
beled with [35S]methionine for 15 min then chased for 
the indicated periods. At each time point, homogenates 
were prepared  and exposed to Na2CO3 (pH  11), then 
centrifuged into supernatant (S) and pellet (P) fractions 
as detailed in Materials and Methods. Each fraction was 
then precipitated with anti-HBsAg and the precipitated 
products visualized by SDS-PAGE  and autoradiography. 
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which time they become carbonate extractable. Since mor- 
phologically mature 22-nm particles have been observed by 
electron microscopy in the ER lumen of infected and stably 
transformed cells (9,  16), we assume that the particles ex- 
truded into the ER lumen represent the fully assembled lipo- 
protein complex. However, we cannot exclude the possibility 
that further associations with lipids occur en route to the cell 
Figure 4. A model for the biogenesis of HBsAg particles. Particle 
formation is schematized as occurring in several steps. The process 
begins with the synthesis of transmembrane p24s in the ER mem- 
brane (step 1). For simplicity, the monomers are depicted as having 
a single transmembrane domain, although in reality each subunit 
is known to span the bilayer at least twice (6). Within 40 min, all 
of  this material has become protease resistant, which may represent 
simply a conformational change (not shown) or aggregation in the 
membrane (as depicted in step 2), or both. At this stage, the antigen 
is still integrally associated with the bilayer. Over the ensuing 3 h, 
the bulk of this material is transferred to the ER lumen (steps 3 and 
4) as a subviral particle no longer integrally associated with the 
membrane. Lipid is retained in the extruded particle; the structure 
of the lipid in the mature particle is poorly understood but may no 
longer be in a bilayer (see text). The reorganized lipid is depicted 
schematically with stipple. Once formed, the complex is rapidly ex- 
ported to the cell exterior via the normal vesicular pathway (not 
shown). 
surface. The rate-limiting step in this export process would 
appear to be extrusion into the ER, since the half-time for 
carbonate extractability is very similar to the half-time for 
secretion. 
From the ER lumen the particles are rapidly exported from 
the cell via the constitutive pathway of vesicular transport. 
Particles traverse the Golgi cisterns, since secreted HBsAg 
glycoproteins are endoglycosidase H  resistant, whereas all 
intracellular gp27s chains are susceptible to this enzyme (17, 
22). (The absence of intracellular endoglycosidase H-resis- 
tant HBsAg is also consistent with our postulate that the rate- 
limiting step in export is assembly in the ER.) The fact that 
export of HBsAg is inhibited by monensin (17) is also indica- 
tive of trans-Golgi  passage of this protein complex. 
These experiments clearly demonstrate that a transmem- 
brane form of HBsAg serves as precursor to the secreted 
form, and indicate that the molecular events leading to the 
export of this complex differ from other known processes for 
protein secretion. Most secreted proteins contain a cleaved 
signal sequence at their amino terminus (1, 2); they are com- 
pletely translocated into the ER lumen cotranslationally, and 
they are not derived from a transmembrane intermediate. By 
contrast, there have been a  number of reports of secreted 
polypeptides which, like HBsAg, are derived from a trans- 
membrane precursor; proteins sharing this feature include 
the secretory component of immunoglobulin A  (15),  trans- 
forming growth factors ¢t and 13 (3,  12), and EGF (10, 21). 
However, in all of these cases, the secreted product is gener- 
ated by proteolytic cleavage of the ectodomain of the larger 
transmembrane precursor. No such cleavage events are re- 
quired to liberate HBsAg. 
The biogenesis of HBsAg particles can also be instruc- 
tively compared to the assembly and budding of enveloped 
viruses. In this case, the analogous transmembrane proteins 
are the envelope glycoproteins that, by interacting with the 
nucleocapsid, participate in a budding event that results in 
virion formation (7). During this process, the envelope gly- 
coproteins undergo lateral interactions in the membrane and 
selectively self-assemble while at the same time excluding 
host cellular proteins  (7).  Maturation of HBsAg particles 
also includes a process of self-association and selective ex- 
clusion of host proteins; however, HBsAg biogenesis is dis- 
tinctive in that participation of other viral components is not 
required for the self-aggregate to be released from the origi- 
nal membrane in which it was embedded. In addition,  al- 
though 22-nm particles contain lipid, the lipid/protein ratio 
of these structures is much lower than that of conventional 
cellular membranes (8), and the behavior of mature HBsAg 
particles at pH 11 also suggests that the proteins are not sim- 
ply embedded in a conventional vesicle-like structure (22). 
If indeed the lipid within the complexes no longer exists as 
a  bilayer, then the extrusion process that delivers HBsAg 
complexes to the ER lumen may well involve a substantial 
reorganization of lipid as well as proteins within the mem- 
brane environment, a feature that would further distinguish 
this process from conventional viral budding events. 
Inspection of the HBsAg primary amino acid sequence re- 
veals several structural features that might be essential for 
directing lhe assembly process. Studies performed with cell- 
free systems established that the hydrophobic sequence at po- 
sitions 80-98 is a membrane-spanning region which directs 
the translocation of the carboxy terminus (5, 6). This trans- 
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regions  (amino  acids  3-22  and  170-226)  are highly  con- 
served between the hepadnaviruses of different species. Any 
or all of these regions might be capable of interacting with 
the membrane lipid bilayer or of promoting lateral interac- 
tions between individual p24s subunits. We are currently ex- 
amining  surface  antigen mutants constructed  in  vitro  to 
define the molecular determinants that direct the assembly 
and export process. Analysis of these mutants with the bio- 
chemical  assays for assembly  intermediates reported here 
should aid in the further elucidation of the mechanism of this 
unusual export process. 
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